<code id='91F4667BA7'></code><style id='91F4667BA7'></style>
    • <acronym id='91F4667BA7'></acronym>
      <center id='91F4667BA7'><center id='91F4667BA7'><tfoot id='91F4667BA7'></tfoot></center><abbr id='91F4667BA7'><dir id='91F4667BA7'><tfoot id='91F4667BA7'></tfoot><noframes id='91F4667BA7'>

    • <optgroup id='91F4667BA7'><strike id='91F4667BA7'><sup id='91F4667BA7'></sup></strike><code id='91F4667BA7'></code></optgroup>
        1. <b id='91F4667BA7'><label id='91F4667BA7'><select id='91F4667BA7'><dt id='91F4667BA7'><span id='91F4667BA7'></span></dt></select></label></b><u id='91F4667BA7'></u>
          <i id='91F4667BA7'><strike id='91F4667BA7'><tt id='91F4667BA7'><pre id='91F4667BA7'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:1814
          Parts of a DNA spotlighted -- Coverage from STAT
          Adobe

          Ring Therapeutics, a gene therapy startup launched by Flagship Pioneering, has laid off just under 20% of its staff, or 19 employees, Flagship confirmed to STAT.

          The move comes as Sonata Therapeutics, another Flagship startup, has let go of a third of its staff, part of a broader hunkering down by platform companies. As funding for private biotechs remains scarce, startups hoping to develop new technologies — always an expensive, setback-ridden process — have had to make tough choices on staffing and priorities.

          advertisement

          Ring had been particularly ambitious. The company is trying to engineer a new class of viruses as vehicles for delivering genes into patients’ cells. These viruses, tiny bugs called anelloviruses, had the potential to be safer and more versatile than the viruses currently used for gene therapy, called AAVs.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more
          Biogen’s boardroom scandal saddles CEO with first crisis
          Biogen’s boardroom scandal saddles CEO with first crisis

          ChrisViehbachertookoverasBiogenCEOinNovember.SuzanneKreiter/Globestaff;PhotoillustrationAlexHogan/ST

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Petition to FDA: Get the lead out of consumer hair dyes

          AlissaAmbrose/STATWASHINGTON—Backin1980,whentheFoodandDrugAdministrationapprovedtheuseofleadacetatei